Jeff Ross
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Cancer-related gene regulation 3
- Melanoma and MAPK Pathways 3
- Histone Deacetylase Inhibitors Research 2
-
- Cancer Genomics and Diagnostics 6
- Protease and Inhibitor Mechanisms 2
- Co-authors
- Christine E. Sheehan (2 shared papers)Norio Azumi (1 shared paper)Bhaskar Kallakury (1 shared paper)Shridevi Karikehalli (1 shared paper)Joseph E. Heiserman (1 shared paper)Gregory P. Leković (1 shared paper)John P. Karis (1 shared paper)Alan Pitt (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (3 papers)Blood (2 papers)International Journal of Gynecological Cancer (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United StatesCzechiaSpain
In The Last Decade
Jeff Ross
22 papers receiving 492 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 194
- Hematology 66
- Oncology 125
- Immunology and Allergy 20
- Surgery 112
Countries citing papers authored by Jeff Ross
This map shows the geographic impact of Jeff Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Ross more than expected).
Fields of papers citing papers by Jeff Ross
This network shows the impact of papers produced by Jeff Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Ross. The network helps show where Jeff Ross may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. | 2001 | 255 |
| 2 | 2009 | 103 | |
| 3 | 2014 | 42 | |
| 4 | Expression of matrix metalloproteinases 3, 10 and 11 (stromelysins 1, 2 and 3) and matrix metalloproteinase 7 (matrilysin) by cancer cells in non-small cell lung neoplasms. Clinicopathologic studies. | 2006 | 23 |
| 5 | Downregulation of plasma membrane expression/cytoplasmic accumulation of beta-catenin predicts shortened survival in non-small cell lung cancer. A clinicopathologic study of 100 cases. | 2003 | 22 |
| 6 | Measurements of estrogen receptor and reporter genes from microarrays determine receptor status and time to recurrence following adjuvant tamoxifen therapy. | 2005 | 10 |
| 7 | 2017 | 8 | |
| 8 | Role of DNA content determination by image analysis in confirmation of dysplasia in Barrett's esophagus. | 1994 | 8 |
| 9 | 2005 | 8 | |
| 10 | 2024 | 5 | |
| 11 | 2015 | 3 | |
| 12 | 2019 | 2 | |
| 13 | 2014 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2017 | 2 | |
| 16 | 2005 | 2 | |
| 17 | Nuclear DNA content and clinical follow-up in resected pancreatic adenocarcinoma. | 1993 | 2 |
| 18 | 2025 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2020 | 1 |
About Jeff Ross
Jeff Ross is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 22 papers that have together received 504 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Cancer-related gene regulation (3 papers), Cancer Mechanisms and Therapy (3 papers), Melanoma and MAPK Pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers), Protease and Inhibitor Mechanisms (2 papers), Lung Cancer Research Studies (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (194 citations), Hematology (66 citations), Oncology (125 citations), Immunology and Allergy (20 citations) and Surgery (112 citations). Jeff Ross has collaborated with scholars based in United States, Czechia and Spain. Frequent co-authors include Christine E. Sheehan, Norio Azumi, Bhaskar Kallakury, Shridevi Karikehalli, Joseph E. Heiserman, Gregory P. Leković, John P. Karis, Alan Pitt, Bruce L. Dean and Neil R. Crawford. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Blood, International Journal of Gynecological Cancer and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.